Literature DB >> 23601806

Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.

Brian P Brooks1, Amy H Thompson, Rachel J Bishop, Janine A Clayton, Chi-Chao Chan, Ekaterini T Tsilou, Wadih M Zein, Deborah Tamura, Sikandar G Khan, Takahiro Ueda, Jennifer Boyle, Kyu-Seon Oh, Kyoko Imoto, Hiroki Inui, Shin-Ichi Moriwaki, Steffen Emmert, Nicholas T Iliff, Porcia Bradford, John J Digiovanna, Kenneth H Kraemer.   

Abstract

OBJECTIVE: Xeroderma pigmentosum (XP) is a rare autosomal recessive disease caused by mutations in DNA repair genes. Clinical manifestations of XP include mild to extreme sensitivity to ultraviolet radiation resulting in inflammation and neoplasia in sun-exposed areas of the skin, mucous membranes, and ocular surfaces. This report describes the ocular manifestations of XP in patients systematically evaluated in the Clinical Center at the National Institutes of Health.
DESIGN: Retrospective observational case series. PARTICIPANTS: Eighty-seven participants, aged 1.3 to 63.4 years, referred to the National Eye Institute (NEI) for examination from 1964 to 2011. Eighty-three patients had XP, 3 patients had XP/Cockayne syndrome complex, and 1 patient had XP/trichothiodystrophy complex.
METHODS: Complete age- and developmental stage-appropriate ophthalmic examination. MAIN OUTCOME MEASURES: Visual acuity; eyelid, ocular surface, and lens pathology; tear film and tear production measures; and cytologic analysis of conjunctival surface swabs.
RESULTS: Of the 87 patients, 91% had at least 1 ocular abnormality. The most common abnormalities were conjunctivitis (51%), corneal neovascularization (44%), dry eye (38%), corneal scarring (26%), ectropion (25%), blepharitis (23%), conjunctival melanosis (20%), and cataracts (14%). Thirteen percent of patients had some degree of visual axis impingement, and 5% of patients had no light perception in 1 or both eyes. Ocular surface cancer or a history of ocular surface cancer was present in 10% of patients. Patients with an acute sunburning skin phenotype were less likely to develop conjunctival melanosis and ectropion but more likely to develop neoplastic ocular surface lesions than nonburning patients. Some patients also showed signs of limbal stem cell deficiency.
CONCLUSIONS: Our longitudinal study reports the ocular status of the largest group of patients with XP systematically examined at 1 facility over an extended period of time. Structural eyelid abnormalities, neoplasms of the ocular surface and eyelids, tear film and tear production abnormalities, ocular surface disease and inflammation, and corneal abnormalities were present in this population. Burning and nonburning patients with XP exhibit different rates of important ophthalmologic findings, including neoplasia. In addition, ophthalmic characteristics can help refine diagnoses in the case of XP complex phenotypes. DNA repair plays a major role in protection of the eye from sunlight-induced damage.
Copyright © 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23601806      PMCID: PMC3702678          DOI: 10.1016/j.ophtha.2012.12.044

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  55 in total

Review 1.  Geometrical assessment of ocular exposure to environmental UV radiation--implications for ophthalmic epidemiology.

Authors:  D H Sliney
Journal:  J Epidemiol       Date:  1999-12       Impact factor: 3.211

2.  Cancer and neurologic degeneration in xeroderma pigmentosum: long term follow-up characterises the role of DNA repair.

Authors:  Porcia T Bradford; Alisa M Goldstein; Deborah Tamura; Sikandar G Khan; Takahiro Ueda; Jennifer Boyle; Kyu-Seon Oh; Kyoko Imoto; Hiroki Inui; Shin-Ichi Moriwaki; Steffen Emmert; Kristen M Pike; Arati Raziuddin; Teri M Plona; John J DiGiovanna; Margaret A Tucker; Kenneth H Kraemer
Journal:  J Med Genet       Date:  2010-11-19       Impact factor: 6.318

Review 3.  Ophthalmic manifestations and histopathology of xeroderma pigmentosum: two clinicopathological cases and a review of the literature.

Authors:  Hema L Ramkumar; Brian P Brooks; Xiaoguang Cao; Deborah Tamura; John J Digiovanna; Kenneth H Kraemer; Chi-Chao Chan
Journal:  Surv Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 6.048

4.  Central corneal pachymetry in patients undergoing laser in situ keratomileusis.

Authors:  F W Price; D L Koller; M O Price
Journal:  Ophthalmology       Date:  1999-11       Impact factor: 12.079

5.  Effect of age on the endothelial cell count in the normal eye.

Authors:  R S Wilson; M J Roper-Hall
Journal:  Br J Ophthalmol       Date:  1982-08       Impact factor: 4.638

Review 6.  Xeroderma pigmentosum in black South Africans.

Authors:  W K Jacyk
Journal:  Int J Dermatol       Date:  1999-07       Impact factor: 2.736

7.  The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.

Authors:  K H Kraemer; M M Lee; A D Andrews; W C Lambert
Journal:  Arch Dermatol       Date:  1994-08

8.  Premalignant melanosis of the conjunctiva and the cornea in xeroderma pigmentosum.

Authors:  A D Paridaens; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1992-02       Impact factor: 4.638

9.  Defects in the DNA repair and transcription gene ERCC2 in the cancer-prone disorder xeroderma pigmentosum group D.

Authors:  K Takayama; E P Salazar; A Lehmann; M Stefanini; L H Thompson; C A Weber
Journal:  Cancer Res       Date:  1995-12-01       Impact factor: 12.701

10.  Ocular involvement in xeroderma pigmentosum.

Authors:  D E Gaasterland; M M Rodrigues; A N Moshell
Journal:  Ophthalmology       Date:  1982-08       Impact factor: 12.079

View more
  20 in total

Review 1.  Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.

Authors:  Rosella Abeti; Anna Zeitlberger; Colm Peelo; Hiva Fassihi; Robert P E Sarkany; Alan R Lehmann; Paola Giunti
Journal:  Br J Pharmacol       Date:  2019-01-23       Impact factor: 8.739

Review 2.  Living with xeroderma pigmentosum: comprehensive photoprotection for highly photosensitive patients.

Authors:  Deborah Tamura; John J DiGiovanna; Sikandar G Khan; Kenneth H Kraemer
Journal:  Photodermatol Photoimmunol Photomed       Date:  2014-02-19       Impact factor: 3.135

3.  Clinicopathological Features of Ophthalmic Neoplasms Arising in the Setting of Xeroderma Pigmentosum.

Authors:  Maria J Suarez; Roxana Rivera-Michlig; Sander Dubovy; Fausto J Rodriguez
Journal:  Ocul Oncol Pathol       Date:  2015-11-12

4.  Macular and Retinal Nerve Fibre Layer Thinning in Xeroderma Pigmentosum: A Cross-sectional Study.

Authors:  Anna M Gruener; Ana M S Morley
Journal:  Neuroophthalmology       Date:  2018-05-22

Review 5.  Xeroderma Pigmentosum.

Authors:  Jennifer O Black
Journal:  Head Neck Pathol       Date:  2016-03-14

6.  ADAM3A copy number gains occur in a subset of conjunctival squamous cell carcinoma and its high grade precursors.

Authors:  M Adelita Vizcaino; Abeer Z Tabbarah; Laura Asnaghi; Azza Maktabi; Allen O Eghrari; Divya Srikumaran; Charles G Eberhart; Fausto J Rodriguez
Journal:  Hum Pathol       Date:  2019-09-05       Impact factor: 3.466

Review 7.  Forty years of research on xeroderma pigmentosum at the US National Institutes of Health.

Authors:  Kenneth H Kraemer; John J DiGiovanna
Journal:  Photochem Photobiol       Date:  2015-01-08       Impact factor: 3.421

8.  Ocular surface squamous neoplasia - Review of etio-pathogenesis and an update on clinico-pathological diagnosis.

Authors:  Ruchi Mittal; Suryasnata Rath; Geeta Kashyap Vemuganti
Journal:  Saudi J Ophthalmol       Date:  2013-07

Review 9.  Xeroderma Pigmentosum: A Model for Human Premature Aging.

Authors:  Elizabeth R H Rizza; John J DiGiovanna; Sikandar G Khan; Deborah Tamura; Jack D Jeskey; Kenneth H Kraemer
Journal:  J Invest Dermatol       Date:  2021-01-09       Impact factor: 8.551

10.  Why? What? How? Using an Intervention Mapping approach to develop a personalised intervention to improve adherence to photoprotection in patients with Xeroderma Pigmentosum.

Authors:  Jessica Walburn; Kirby Sainsbury; Lesley Foster; John Weinman; Myfanwy Morgan; Sam Norton; Martha Canfield; Paul Chadwick; Bob Sarkany; Vera Araújo-Soares
Journal:  Health Psychol Behav Med       Date:  2020-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.